Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01429-07
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

Current HIV Research
VirologyInfectious Diseases
2009English

Mortality and Long-Term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2013English

Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

The HIV Protease Inhibitor Lopinavir/Ritonavir (Kaletra) Alters the Growth, Differentiation and Proliferation of Primary Gingival Epithelium

HIV Medicine
Health PolicyInfectious DiseasesPharmacology
2010English

Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings

AIDS
Infectious DiseasesAllergyImmunology
2012English

Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2010English

Comparative Effectiveness of Darunavir 1,200 Mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients

AIDS Research and Treatment
ImmunologyPublic HealthAllergyEnvironmentalDermatologyInfectious DiseasesOccupational Health
2013English

Lopinavir/Ritonavir Population Pharmacokinetics in Neonates and Infants

British Journal of Clinical Pharmacology
Pharmacology
2011English

Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy